Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Eosinophilic Disorders
•
Primary Care
How long would you treat severe eosinophilic asthma/pneumonia with q4week anti-IL5 therapy prior to tapering?
Related Questions
What treatment approach do you suggests for a patient with nasal polyp disease and asthma who was improved on dupilumab, but over last 2 years has begun to have increased nasal symptoms and rising eosinophil counts?
Would you ever use dupilumab for atopic dermatitis in a patient who also has EGPA?
How often do you monitor the eosinophil count after initiating anti-IL5 therapy for HAE?
Do mRNA vaccines lead to increased rates of acute/chronic urticaria?
Do you continue shots when a patient transfers under your care and has been receiving less than effective doses of AIT, but insist they have been effective?
Is addition of SLIT likely to provide additional benefit for isolated dust mite allergy that is not completely treated with SCIT?
Does food sensitivity testing for IgG subclasses help guide your management of food allergy?
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
Do you recommend food elimination diets for GI eosinophilic disorder not affecting the esophagus?
Do you recommend IM Kenalog injection for refractory CRSwNP in a patient already on maximal therapy?
